SIA
Soltis Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Sell |
1,419
-7,113
| -83% | -$2.88M | 0.05% | 241 |
|
|
2025
Q1 | $4.25M | Buy |
8,532
+906
| +12% | +$451K | 0.38% | 75 |
|
|
2024
Q4 | $3.97M | Buy |
7,626
+6,366
| +505% | +$3.31M | 0.37% | 77 |
|
|
2024
Q3 | $779K | Buy |
1,260
+4
| +0.3% | +$2.47K | 0.08% | 173 |
|
|
2024
Q2 | $695K | Sell |
1,256
-81
| -6% | -$44.8K | 0.07% | 176 |
|
|
2024
Q1 | $777K | Sell |
1,337
-955
| -42% | -$555K | 0.09% | 159 |
|
|
2023
Q4 | $1.22M | Sell |
2,292
-1,143
| -33% | -$607K | 0.14% | 132 |
|
|
2023
Q3 | $1.74M | Sell |
3,435
-1,298
| -27% | -$657K | 0.22% | 114 |
|
|
2023
Q2 | $2.47M | Sell |
4,733
-25
| -0.5% | -$13K | 0.29% | 94 |
|
|
2023
Q1 | $2.74M | Sell |
4,758
-1,622
| -25% | -$935K | 0.35% | 87 |
|
|
2022
Q4 | $3.51M | Buy |
6,380
+2,043
| +47% | +$1.13M | 0.46% | 64 |
|
|
2022
Q3 | $2.2M | Buy |
4,337
+48
| +1% | +$24.3K | 0.33% | 79 |
|
|
2022
Q2 | $2.33M | Sell |
4,289
-32
| -0.7% | -$17.4K | 0.34% | 74 |
|
|
2022
Q1 | $2.55M | Buy |
4,321
+40
| +0.9% | +$23.6K | 0.35% | 70 |
|
|
2021
Q4 | $2.86M | Buy |
4,281
+1,123
| +36% | +$749K | 0.4% | 53 |
|
|
2021
Q3 | $1.8M | Sell |
3,158
-2,305
| -42% | -$1.32M | 0.28% | 76 |
|
|
2021
Q2 | $2.76M | Buy |
5,463
+911
| +20% | +$460K | 0.44% | 42 |
|
|
2021
Q1 | $2.08M | Buy |
4,552
+711
| +19% | +$324K | 0.38% | 50 |
|
|
2020
Q4 | $1.79M | Buy |
3,841
+2,876
| +298% | +$1.34M | 0.33% | 51 |
|
|
2020
Q3 | $426K | Sell |
965
-4
| -0.4% | -$1.77K | 0.1% | 135 |
|
|
2020
Q2 | $351K | Buy |
969
+7
| +0.7% | +$2.54K | 0.09% | 141 |
|
|
2020
Q1 | $273K | Hold |
962
| – | – | 0.08% | 130 |
|
|
2019
Q4 | $313K | Buy |
+962
| New | +$313K | 0.06% | 117 |
|